DJIA 17,804.80 26.65 0.15%
NASDAQ 4,765.38 16.98 0.36%
S&P 500 2,070.65 9.42 0.46%
market minute promo

39.05 -1.43 (-3.53%)

Quote as of


company name or ticker

Recent Quotes

XLRN $39.05 -3.53%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.42
Previous Close $40.48
Daily Range $37.45 - $40.42
52-Week Range $23.61 - $57.89
Market Cap $1.3B
P/E Ratio 28.71
Dividend (Yield) $0.00 (0.0%)
Volume 1,211,509
Average Daily Volume 354,009
Current FY EPS -$1.25

Sector

Industry

CONTROLADORA VUELA SPON ADR REPR 10 CPOS (XLRN) Description

CONTROLADORA VUELA SPON ADR REPR 10 CPOS Website: http://www.acceleronpharma.com/

News & Commentary

3 Large Cap Biotech Stocks That Could Pay Dividends, But Won't

Gilead Sciences, Celgene, and Biogen all have rock-solid financials, but none are likely to pay a dividend anytime soon.

Acceleron Pharma, Inc. (XLRN) in Focus: Stock Soars 13.6% - Tale of the Tape

Monday Sector Leaders: Insurance Brokers, Biotechnology Stocks

Health Care Sector Update for 12/08/2014: XLRN,CELG,CBST,MRK,ALR

Celgene, Acceleron Pharma Report Prelim. Data from Ongoing Phase 2 Trials in Patients with Lower Ris

Celgene, Acceleron Pharma Report Prelim. Data from Ongoing Phase 2 Trials in Patients with Lower Risk MDS:: Luspatercept, Sotatercept Increased Hemoglobin Levels

Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Ce

Mid-Day Gainers From December 8: Cubist Pharmaceuticals, Acceleron Pharma, Calithera Biosciences, Cempra, Isis Pharmaceuticals

Acceleron Pharma (XLRN) Strong On High Relative Volume Today

Acceleron Drugs Reduce Anemia Caused by Rare Blood Disorders

Will Acceleron (XLRN) Continue to Surge Higher? - Tale of the Tape

Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2014 Results - Earnings Call Transcript

See More XLRN News...